Does retatrutide cause weight loss?
In a placebo-controlled trial in people with obesity, it led to substantial weight loss. It’s still an experimental drug without FDA approval, and a trial result doesn’t verify a bottle sold online.
14 of 16 in Every Peptide Explained in 10 Minutes (Human Studies Only)
What the human studies found
- Research here matches a widely discussed goal: weight loss.
- In the 2023 phase 2 trial in people with obesity, retatrutide led to substantial weight loss compared with placebo. The most common side effects were digestive problems, including nausea and diarrhea.
- As of October 2, 2026, it remains an experimental drug without FDA approval. The FDA says retatrutide isn’t a component of any approved drug.
- A result from a controlled trial doesn’t verify the contents of a separate bottle sold online.
The studies (1)
Also cited
We checked the human research behind 16 peptides. The question wasn’t just “is there a study?” It was “does that study support the pitch?” For each one: who took part, what was measured, and what actually changed.
Watch all 16, explained: the film on YouTube · 9:42An approval, a trial or a paper belongs to a particular substance and a particular use. None of it verifies the contents of a bottle sold online. This is an investigation of the claims, not a guide to taking them.
Get the free 3-question checklist
The three questions we asked of all 16 peptides, plus each new investigation when it drops. No spam, unsubscribe anytime.